LexaGene Holdings Inc. — Form D/A

LexaGene Holdings Inc. of Beverly, MA, a company, filed a Form D amendment with the SEC on 2022-02-28. The offering totals $11.5M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
DARYL REBECKDirectorVANCOUVER, A1
DARYL REBECKExecutive OfficerVANCOUVER, A1
JOSEPH CARUSODirectorPhiladelphia, PA
Steven ArmstrongExecutive OfficerMiami, FL
JANE SYKESDirectorBeverly, MA
STEPHEN MASTROCOLADirectorBeverly, MA
THOMAS SLEZAKDirectorBeverly, MA
JEFFREY MITCHELLExecutive OfficerBeverly, MA
JOHN (JACK) REGANDirectorBeverly, MA
JOHN (JACK) REGANExecutive OfficerBeverly, MA
JANE R SYKESDirectorBeverly, MA
JOSEPH R CARUSODirectorBeverly, MA
STEPHEN J MASTROCOLADirectorBeverly, MA
THOMAS R SLEZAKDirectorBeverly, MA
Tom SlezakDirectorBeverly, MA
Manohar FurtadoDirectorBeverly, MA
DARYL M REBECKDirectorBeverly, MA
DARYL M REBECKExecutive OfficerBeverly, MA
DARYL M REBECKRelated PersonBeverly, MA
Jeffrey M MitchellExecutive OfficerBeverly, MA
Jeffrey M MitchellRelated PersonBeverly, MA
Joseph M CarusoDirectorBeverly, MA
Joseph M CarusoRelated PersonBeverly, MA
Manohar R FurtadoDirectorBeverly, MA
Manohar R FurtadoRelated PersonBeverly, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2022-11-16D$1.6M$1.6M
2022-02-17D$8.1M$3.5M
2022-02-16D/A$8.1M$3.5M
2020-10-05D$1.7M$1.0M
2019-11-07D$2.4M$999K
2019-04-15D$266K$115K
2010-07-29D$21K$21K

More